A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease
<p><strong>Background</strong> Bulk cancer and minimal residual disease (MRD) are characterised by different molecular drivers and therefore necessitate different therapeutic strategies. However, there are currently no 3D models that can faithfully recapitulate MRD ex vivo for ther...
Príomhchruthaitheoirí: | Yang, X, Artibani, M, Jin, Y, Aggarwal, A, Zhang, Y, Munoz-Galvan, S, Mikhailova, E, Rai, L, Mukherjee, N, Krishna Kumar, R, Albukhari, A, Zhou, L, Ahmed, AA, Bayley, H |
---|---|
Formáid: | Internet publication |
Teanga: | English |
Foilsithe / Cruthaithe: |
2023
|
Míreanna comhchosúla
Míreanna comhchosúla
-
3D Microtumours fabricated by microfluidics: applications in ovarian cancer
de réir: Yang, X
Foilsithe / Cruthaithe: (2023) -
Role of immunotherapy in ovarian cancer: a narrative review
de réir: Romanchik, D, et al.
Foilsithe / Cruthaithe: (2022) -
Retraction Note: Visualising the dynamics of live pancreatic microtumours self-organised through cell-in-cell invasion
de réir: Yukiko Miyatake, et al.
Foilsithe / Cruthaithe: (2024-10-01) -
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
de réir: Artibani, M, et al.
Foilsithe / Cruthaithe: (2021) -
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
de réir: Mara Artibani, et al.
Foilsithe / Cruthaithe: (2021-06-01)